---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-068082"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-07-15T23:59:59+00:00"
generated_at: "2026-05-18T06:28:13.476817+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# ReShape furnishes investor presentation for pending Vyome merger, new ticker HIND

## Summary
- Filed investor presentation slides on July 15, 2025 in connection with proposed merger with Vyome Therapeutics.
- Presentation describes Vyome as a US-India clinical-stage platform focused on immuno-inflammation assets.
- Combined company expected to trade on Nasdaq under ticker symbol HIND (pending stockholder and regulatory approvals).
- Merger and asset sale subject to stockholder vote; joint proxy statement/prospectus filed June 24, 2025.

## SEC filing metadata
- accession: 0001104659-25-068082
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-07-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925068082/0001104659-25-068082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925068082/tm2519769d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-068082
- JSON: https://secwatch.observer/filing/0001104659-25-068082.json
- Plain text: https://secwatch.observer/filing/0001104659-25-068082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.